225 related articles for article (PubMed ID: 32299314)
1. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
2. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
Randolph LA; Walker CK; Nguyen AT; Zachariah SR
J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
[TBL] [Abstract][Full Text] [Related]
3. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
[No Abstract] [Full Text] [Related]
4. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
5. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
6. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
[TBL] [Abstract][Full Text] [Related]
7. Clinical, Economic, and Organizational Impact of the Clinical Pharmacist in an Orthopedic and Trauma Surgery Department.
Renaudin P; Coste A; Audurier Y; Berbis J; Canovas F; Jalabert A; Castet-Nicolas A; Mercier G; Villiet M; Dagneaux L; Breuker C
J Patient Saf; 2021 Dec; 17(8):e1507-e1513. PubMed ID: 30365407
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
Chen PZ; Wu CC; Huang CF
J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
[TBL] [Abstract][Full Text] [Related]
9. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
10. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
[TBL] [Abstract][Full Text] [Related]
11. Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.
Nguyen AL
J Oncol Pharm Pract; 2023 Sep; 29(6):1369-1373. PubMed ID: 36002947
[TBL] [Abstract][Full Text] [Related]
12. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
[TBL] [Abstract][Full Text] [Related]
13. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
Kim HJ; Lee S; Lee YJ; Kim S; Jo YH; Cho YS; An HY; Hong KT; Choi JY; Kang HJ; Shin HY; Lee JY
J Oncol Pharm Pract; 2023 Mar; 29(2):319-325. PubMed ID: 34931912
[TBL] [Abstract][Full Text] [Related]
15. Description and financial impact of ambulatory care pharmacy team interventions within an underserved patient population.
Hasham S; Moye-Dickerson P; Thurston MM
Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S42-S48. PubMed ID: 36371741
[TBL] [Abstract][Full Text] [Related]
16. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
Chuang LC; Sutton JD; Henderson GT
Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
[TBL] [Abstract][Full Text] [Related]
17. Cost savings and avoidance from clinical interventions.
Mutnick AH; Sterba KJ; Peroutka JA; Sloan NE; Beltz EA; Sorenson MK
Am J Health Syst Pharm; 1997 Feb; 54(4):392-6. PubMed ID: 9043561
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.
Lee GW; Mathur AD; Andrick BJ; Leese E; Zally D; Gatson NTN
J Oncol Pharm Pract; 2020 Dec; 26(8):1937-1941. PubMed ID: 32938297
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of pharmacist interventions in pediatric ambulatory care clinics.
Yung E; McNicol M; Lewis D; Fischer J; Petkus K; Sebastian S; Abdel-Rasoul M; Schmuhl K; Wise K
J Am Pharm Assoc (2003); 2021; 61(2):198-205.e1. PubMed ID: 33358098
[TBL] [Abstract][Full Text] [Related]
20. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
